-transparent.png){kind=logo}
The effect of medroxyprogesterone acetate 10 mg BID alone, conjugated estrogens alone or in a combination regimen for the prevention of osteoporosis was determined in 36 postmenopausal women using single photon densitometry. No significant differences in cortical or trabecular bone mass over time were detected in women between the three treatment groups, although a slight increase in bone mass was noted in women with the combined therapy. Medroxyprogesterone acetate appears efficacious in preventing postmenopausal osteoporosis, and may be especially useful in women with contraindications to estrogen replacement therapy.
Related Publications
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
December 2002,
Zhonghua yi xue za zhi,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
July 2018,
Oncotarget,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
October 2002,
The Journal of family practice,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
March 2002,
Circulation,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
October 2001,
Circulation,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
July 2014,
The Journal of steroid biochemistry and molecular biology,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
January 2001,
The American journal of cardiology,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
August 1996,
Maturitas,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
June 1980,
Gynakologische Rundschau,
S G McNeeley, and
J S Schinfeld, and
T G Stovall, and
F W Ling, and
B H Buxton
February 1999,
The Journal of the Oklahoma State Medical Association,
